[{"NetIncomeLoss_1_Q1_USD":-50532000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":30105017.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":27781000.0,"DerivativeLiabilitiesCurrent_0_Q1_USD":930000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-32784000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":7038000.0,"PaymentsToAcquireInvestments_1_Q1_USD":83381000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-9000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":928000.0,"AssetsCurrent_0_Q1_USD":217755000.0,"OperatingLeaseExpense_1_Q1_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6746081.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":80000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":920000.0,"CommonStockSharesIssued_0_Q1_shares":30420789.0,"Assets_0_Q1_USD":222241000.0,"ShareBasedCompensation_1_Q1_USD":5285000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1854000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":9479000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":9570594.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":80000.0,"ShortTermInvestments_0_Q1_USD":122436000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":653000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3622000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":48600000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-74000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-16000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5000.0,"CommonStockValue_0_Q1_USD":3000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":90000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":38134000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":6594000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost_1_Q1_USD":300000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-50615000.0,"OtherAssetsNoncurrent_0_Q1_USD":1426000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":90677000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2452000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":357583000.0,"Liabilities_0_Q1_USD":88358000.0,"OperatingLeaseLiability_0_Q1_USD":3105000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":517000.0,"CommonStockSharesOutstanding_0_Q1_shares":30198129.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_1_Q1_USD":334000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-50527000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5285000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-25210000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":891000.0,"LiabilitiesCurrent_0_Q1_USD":35022000.0,"AccountsPayableCurrent_0_Q1_USD":5658000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4642000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-9000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":89221000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.08,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":160000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":90677000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"OperatingLeasePayments_1_Q1_USD":212000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1206000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-51409000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-223703000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-6000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":3000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":230000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":112000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-47613000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":122436000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":6914000.0,"InvestmentIncomeInterest_1_Q1_USD":149000.0,"PreferredStockValue_0_Q1_USD":0.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_1_Q1_USD":-334000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":222241000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5285000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q1_USD":-83000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":653000.0,"OperatingExpenses_1_Q1_USD":47613000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.68,"ProfitLoss_1_Q1_USD":-50532000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":24000.0,"StockholdersEquity_0_Q1_USD":133883000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3039000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":2822000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]